Ludwig Cancer Research welcomes Mikaël Pittet to Ludwig Lausanne miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In his new book, <em>Ravenous</em>, Johns Hopkins faculty member Sam Apple explains how Nobel laureate Otto Warburg's once disregarded cancer metabolism research has undergone a major resurgence
Old West: “Investment in Rafael Holdings (RFL) Represents an Extremely Asymmetric Opportunity”
Old West Investment Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. An average return of 25% was delivered by the fund for the Q1 of 2021, ahead of its S&P 500 benchmark that delivered a 6% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Old West Investment Management, in their Q1 2021 investor letter, mentioned Rafael Holdings, Inc. (NYSE: RFL), and shared their insights on the company. Rafael Holdings, Inc. is a Newark, New Jersey-based clinical-stage oncology pharmaceutical company that currently has a $682.7 million market capitalization. Since the beginning of the year, RFL delivered an impressive 76.72% return, extending its 12-month gains to 192.06%. As of April 28, 2021, the stock closed at $41.38 per share.
Biden s revamped cancer moonshot doubles down on advancing cures msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Ludwig Cancer Research announced the launch Tuesday of the newest branch of the Ludwig Institute for Cancer Research, which will be based at Princeton University. The Ludwig Princeton branch will be dedicated to the study of cancer metabolism.
Ludwig Princeton will be directed by chemical biologist and cancer researcher Joshua Rabinowitz, a professor in the chemistry department and the Lewis-Sigler Institute for Integrative Genomics at the university. Rabinowitz has made foundational contributions to the field of metabolomics, which is the large-scale, quantitative analysis of metabolite. He is a leader in the development and application of new technologies for the dynamic analysis of metabolic processes. His laboratory has applied this expertise to the dissection of cancer metabolism and is devising candidate cancer therapies based on the lab’s discoveries.